Ulrik Mathiesen

3.7k total citations · 1 hit paper
21 papers, 2.8k citations indexed

About

Ulrik Mathiesen is a scholar working on Epidemiology, Hepatology and Health Information Management. According to data from OpenAlex, Ulrik Mathiesen has authored 21 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 8 papers in Hepatology and 4 papers in Health Information Management. Recurrent topics in Ulrik Mathiesen's work include Liver Disease Diagnosis and Treatment (14 papers), Hepatitis B Virus Studies (5 papers) and Artificial Intelligence in Healthcare (4 papers). Ulrik Mathiesen is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Hepatitis B Virus Studies (5 papers) and Artificial Intelligence in Healthcare (4 papers). Ulrik Mathiesen collaborates with scholars based in Sweden, Poland and United Kingdom. Ulrik Mathiesen's co-authors include G. Bodemar, Stergios Kechagias, Mattias Ekstedt, Lennart Franzén, Marika Holmqvist, Lars Thorelius, L Franzén, Aril Frydén, Ulla Foberg and Lars Jacobsson and has published in prestigious journals such as Hepatology, Journal of Hepatology and Journal of Internal Medicine.

In The Last Decade

Ulrik Mathiesen

19 papers receiving 2.7k citations

Hit Papers

Long‐term follow‐up of patients with NAFLD and elevated l... 2006 2026 2012 2019 2006 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrik Mathiesen Sweden 10 2.6k 1.2k 1.1k 528 379 21 2.8k
Elizabeth E. Hespenheide United States 11 2.0k 0.8× 963 0.8× 882 0.8× 443 0.8× 443 1.2× 13 2.3k
Dev Samarasinghe Australia 14 2.0k 0.8× 706 0.6× 1.0k 0.9× 248 0.5× 339 0.9× 22 2.3k
Svanhildur Hafliðadóttir Norway 6 2.6k 1.0× 905 0.7× 1.6k 1.4× 388 0.7× 364 1.0× 8 2.7k
Janet C. Shaw United States 7 1.9k 0.7× 855 0.7× 825 0.7× 338 0.6× 496 1.3× 9 2.4k
Miguel Carneiro de Moura Portugal 21 2.0k 0.8× 680 0.6× 1.1k 0.9× 367 0.7× 295 0.8× 73 2.6k
Licet Gonzalez‐Fabian Cuba 6 2.2k 0.9× 1.1k 0.9× 971 0.9× 338 0.6× 390 1.0× 6 2.4k
Raluca Pais France 21 1.9k 0.7× 793 0.7× 865 0.8× 309 0.6× 332 0.9× 59 2.3k
Heather Lafferty United Kingdom 3 2.1k 0.8× 705 0.6× 1.2k 1.1× 284 0.5× 295 0.8× 6 2.1k
Kittichai Promrat United States 16 2.4k 0.9× 1.1k 0.9× 1.2k 1.0× 311 0.6× 340 0.9× 34 2.8k
Luis Calzadilla Bertot Australia 16 3.2k 1.2× 1.5k 1.2× 1.6k 1.4× 471 0.9× 564 1.5× 38 3.6k

Countries citing papers authored by Ulrik Mathiesen

Since Specialization
Citations

This map shows the geographic impact of Ulrik Mathiesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrik Mathiesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrik Mathiesen more than expected).

Fields of papers citing papers by Ulrik Mathiesen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrik Mathiesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrik Mathiesen. The network helps show where Ulrik Mathiesen may publish in the future.

Co-authorship network of co-authors of Ulrik Mathiesen

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrik Mathiesen. A scholar is included among the top collaborators of Ulrik Mathiesen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrik Mathiesen. Ulrik Mathiesen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ekstedt, Mattias, Lennart Franzén, Ulrik Mathiesen, & Stergios Kechagias. (2011). Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression. Scandinavian Journal of Gastroenterology. 47(1). 108–115. 33 indexed citations
2.
Ekstedt, Mattias, Lennart Franzén, Marika Holmqvist, et al.. (2008). Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology. 44(3). 366–374. 155 indexed citations
3.
Ekstedt, Mattias, Lennart Franzén, Ulrik Mathiesen, et al.. (2007). Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: A histopathological follow-up study. Journal of Hepatology. 47(1). 135–141. 225 indexed citations
4.
Ekstedt, Mattias, Lennart Franzén, Ulrik Mathiesen, et al.. (2006). Long‐term follow‐up of patients with NAFLD and elevated liver enzymes†‡. Hepatology. 44(4). 865–873. 1828 indexed citations breakdown →
5.
Ekstedt, Mattias, L Franzén, Ulrik Mathiesen, G. Bodemar, & Stergios Kechagias. (2006). 690 Statins in patients with elevated liver enzymes because of non-alcoholic fatty liver disease (NAFLD): A clinical and histopathological follow-up study. Journal of Hepatology. 44. S254–S255. 21 indexed citations
6.
Ekstedt, Mattias, L Franzén, Ulrik Mathiesen, et al.. (2006). 91 Survival and causes of death in patients with elevated liver enzymes associated with non-alcoholic fatty liver disease (NAFLD). Journal of Hepatology. 44. S40–S41. 3 indexed citations
7.
Kechagias, Stergios, Mattias Ekstedt, Ulrik Mathiesen, & Lennart Franzén. (2004). [New reference interval for ALAT does not identify subclinical liver disease. Lower limit than the proposed should be used for medical considerations!].. PubMed. 101(38). 2884–7. 1 indexed citations
8.
Mathiesen, Ulrik, L Franzén, Lars Jacobsson, et al.. (2002). Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Digestive and Liver Disease. 34(7). 516–522. 295 indexed citations
9.
Mathiesen, Ulrik. (1999). The Clinical Significance of Slightly to Moderately Increased Liver Transaminase Values in Asymptomatic Patients. Scandinavian Journal of Gastroenterology. 34(1). 85–91. 118 indexed citations
10.
Mathiesen, Ulrik, L Franzén, Aril Frydén, Ulla Foberg, & G. Bodemar. (1999). The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients. European Journal of Gastroenterology & Hepatology. 11(4). 466–466. 16 indexed citations
11.
Babić, Ankica, et al.. (1998). Assessing an AI knowledge-base for asymptomatic liver diseases.. PubMed. 513–7. 1 indexed citations
12.
Foberg, Ulla, Bengt Ekermo, Anders Widell, Ulrik Mathiesen, & Aril Frydén. (1996). Hepatitis C Virus Transmission, 1988–1991, via Blood Components from Donors Subsequently Found to be Anti-HCV-positive. Scandinavian Journal of Infectious Diseases. 28(1). 21–26. 19 indexed citations
13.
Babić, Ankica, G. Bodemar, Ulrik Mathiesen, et al.. (1995). Machine learning to support diagnostics in the domain of asymptomatic liver disease.. PubMed. 8 Pt 1. 809–13. 3 indexed citations
14.
Mathiesen, Ulrik, Eva Nordberg Karlsson, Ulla Foberg, et al.. (1993). Also with a Restrictive Transfusion Policy, Screening with Second-Generation Anti-Hepatitis C Virus Enzyme-Linked Immunosorbent Assay Would Have Reduced Post-Transfusion Hepatitis C after Open-Heart Surgery. Scandinavian Journal of Gastroenterology. 28(7). 581–584. 2 indexed citations
15.
Arnqvist, Hans J., Philippe A. Halban, Ulrik Mathiesen, G Zahnd, & H. von Schenck. (1993). Hypoglycaemia caused by atypical insulin antibodies in a patient with benign monoclonal gammopathy. Journal of Internal Medicine. 234(4). 421–427. 16 indexed citations
16.
Babić, Ankica, et al.. (1993). A statistically rule-based decision support system for the management of patients with suspected liver disease. Medical Informatics. 18(2). 113–130. 2 indexed citations
17.
Mathiesen, Ulrik, et al.. (1993). Influence of “Outliers” on the Association between Laboratory Data and Histopathological Findings in Liver Biopsy. Methods of Information in Medicine. 32(5). 388–395. 4 indexed citations
18.
Mathiesen, Ulrik, Lennart Franzén, Ulla Foberg, et al.. (1992). Empirical modelling versus commonly applied data analysis techniques as used for decision support in liver diseases. 949. 2 indexed citations
19.
Mathiesen, Ulrik, Bengt Ekermo, Ulla Foberg, et al.. (1992). Anti-Hepatitis C Virus Screening Will Reduce the Incidence of Post-Transfusion Hepatitis C Also in Low-Risk Areas. Scandinavian Journal of Gastroenterology. 27(6). 443–448. 9 indexed citations
20.
Wigertz, Ove, et al.. (1991). Integrated approach for designing medical decision support systems with knowledge extracted from clinical databases by statistical methods.. PubMed. 353–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026